Aging with drug use: Theorizing intersectionally with material gerontology and critical drug studies

被引:4
|
作者
Sultan, Aysel [1 ,2 ]
机构
[1] Frankfurt Univ Appl Sci, Inst Addict Res, Frankfurt, Germany
[2] Goethe Univ, Dept Educ Sci, Frankfurt, Germany
关键词
Aging; Critical drug studies; Habitual drug use; Intersectionality; Material gerontology; Older adults; OLDER-PEOPLE; LATER LIFE; ADDICTION; TRENDS; ADULTS; AGE; REALITIES; ILLICIT; OPIOIDS; MATTER;
D O I
10.1016/j.jaging.2021.100990
中图分类号
R4 [临床医学]; R592 [老年病学];
学科分类号
1002 ; 100203 ; 100602 ;
摘要
Rethinking old age and what aging means within the context and materiality of drug use, this paper asks, 'how does drug use matter in old age?' and follows a series of conceptual arguments to link aging studies and critical drug studies with material gerontology in an intersectional analysis. To do this, four research areas are reviewed to conceptualize habitual drug use in old age. First, aging is explored through its biological, subjective, and sociomaterial representations. Secondly, the merits of material gerontological thinking are discussed and developed in connection to marginalization and related intersectionality representing the third and fourth areas of research, respectively. Conceptual results suggest a model of 'embodied-drugged-aging,' an integrated conceptual approach which neither categorizes nor abstracts aging with drug use from its social and material contexts.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Viability assay for Dictyostelium for use in drug studies
    Alexander, H
    Vomund, AN
    Alexander, S
    BIOTECHNIQUES, 2003, 35 (03) : 464 - +
  • [22] On the use of SCRF methods in drug design studies
    Orozco, M
    Colominas, C
    Barril, X
    Luque, FJ
    MOLECULAR MODELING AND PREDICTION OF BIOACTIVITY, 2000, : 129 - 134
  • [23] USE OF RABBITS FOR GI DRUG ABSORPTION STUDIES
    MAEDA, T
    TAKENAKA, H
    YAMAHIRA, Y
    NOGUCHI, T
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (01) : 69 - 73
  • [24] USE OF HUMAN LYMPHOCYTES IN STUDIES OF DRUG ACTION
    SMITH, JL
    FORBES, IJ
    NATURE, 1967, 215 (5100) : 538 - &
  • [25] Use of mass spectrometry for drug metabolism studies
    Korfmacher, WA
    CURRENT DRUG METABOLISM, 2006, 7 (05) : 455 - 455
  • [26] The use of stable isotopes in drug metabolism studies
    Abramson, FP
    SEMINARS IN PERINATOLOGY, 2001, 25 (03) : 133 - 138
  • [27] Is the use of placebo in antihypertensive drug studies ethical?
    Kisch, ES
    JOURNAL OF HYPERTENSION, 1999, 17 (01) : 147 - 147
  • [28] Timing of Concomitant Drug Use in Pharmacoepidemiological Studies
    Abbing-Karahagopian, Victoria
    Gardarsdottir, Helga
    Souverein, Patrick C.
    Klungel, Olaf H.
    Leufkens, Bert G. M.
    Egberts, Toine C. G.
    De Bruin, Marieke L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 423 - 423
  • [29] USE OF ALVEOLAR MACROPHAGES IN ANTIANOXIC DRUG STUDIES
    CAZIN, M
    PALUSZEZAK, D
    POULAIN, V
    DINE, T
    BIANCHI, A
    CAZIN, JC
    AERTS, C
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1988, 10 (04): : 231 - 237
  • [30] Preface - Use of microdialysis in drug delivery studies
    Elmquist, WF
    Sawchuk, RJ
    ADVANCED DRUG DELIVERY REVIEWS, 2000, 45 (2-3) : 123 - 124